Related Experiment Videos
E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressant
L Bertilsson1, M L Dahl-Puustinen, C Nordin
1Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Psychopharmacology Series
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot test.
European annals of allergy and clinical immunology·2022
Pre-treatment allergen-specific IgE analysis and outcomes of allergen immunotherapy.
European annals of allergy and clinical immunology·2021
Effects of a self-guided, web-based activity programme for patients with persistent musculoskeletal pain in primary healthcare: A randomized controlled trial.
European journal of pain (London, England)·2017
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.
The Journal of antimicrobial chemotherapy·2014
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients.
The pharmacogenomics journal·2012
Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group.
Psychopharmacology series·1993
A habenula-enriched GPCR, GPR151, regulates behavioral sensitivity to inflammation.
bioRxiv : the preprint server for biology·2026
Nightmare disorder and depression: Exploring a neglected clinical association.
Journal of psychiatric research·2026
Impact of serotonin transporter deficiency on parvalbumin- and neuropeptide Y-producing neurons of the lateral and basolateral amygdalar nuclei.
Journal of neural transmission (Vienna, Austria : 1996)·2026